Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2023
HIV-1 latency reversal agent boosting is not limited by opioid use
Tyler Lilie, Jennifer Bouzy, Archana Asundi, et al.
The Journal of Infectious Diseases
|
February 23, 2024
Vδ1 Effector and Vδ2 γδ T-Cell Subsets Shift in Frequency and Are Linked to Plasma Inflammatory Markers During Antiretroviral Therapy-Suppressed HIV Infection
Riley M F Pihl, Erika L Smith-Mahoney, Alex Olson, et al.
Journal of the American Heart Association
|
September 29, 2021
Coronary Artery Calcification and Plaque Characteristics in People Living With HIV: A Systematic Review and Meta-Analysis
Cullen Soares, Amjad Samara, Matthew F Yuyun, et al.
Plos One
|
June 4, 2021
End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts
Mohamed Hassan Kamel, Hassan Mahmoud, Aileen Zhen, et al.
Frontiers in Immunology
|
December 21, 2018
Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging
Anna C Belkina, Alina Starchenko, Katherine A Drake, et al.
Ebiomedicine
|
July 19, 2016
Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants
Nina Lin, Oscar A Gonzalez, Ludy Registre, et al.
Open Forum Infectious Diseases
|
March 4, 2015
Plasmodium falciparum Infection Does Not Affect Human Immunodeficiency Virus Viral Load in Coinfected Rwandan Adults
Krishanthi Subramaniam, Rebeca M Plank, Nina Lin, et al.
JACC. Heart Failure
|
April 13, 2020
Heart Failure Outcomes and Associated Factors Among Veterans With Human Immunodeficiency Virus Infection
Sebhat Erqou, Lan Jiang, Gaurav Choudhary, et al.
The Journal of Infectious Diseases
|
June 29, 2012
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256
Timothy J Wilkin, Christina M Lalama, John McKinnon, et al.
The Lancet. HIV
|
October 6, 2017
Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort study
Krista L Dong, Amber Moodley, Douglas S Kwon, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2023
HIV-1 latency reversal agent boosting is not limited by opioid use
Tyler Lilie, Jennifer Bouzy, Archana Asundi, et al.
The Journal of Infectious Diseases
|
February 23, 2024
Vδ1 Effector and Vδ2 γδ T-Cell Subsets Shift in Frequency and Are Linked to Plasma Inflammatory Markers During Antiretroviral Therapy-Suppressed HIV Infection
Riley M F Pihl, Erika L Smith-Mahoney, Alex Olson, et al.
Journal of the American Heart Association
|
September 29, 2021
Coronary Artery Calcification and Plaque Characteristics in People Living With HIV: A Systematic Review and Meta-Analysis
Cullen Soares, Amjad Samara, Matthew F Yuyun, et al.
Plos One
|
June 4, 2021
End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts
Mohamed Hassan Kamel, Hassan Mahmoud, Aileen Zhen, et al.
Frontiers in Immunology
|
December 21, 2018
Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging
Anna C Belkina, Alina Starchenko, Katherine A Drake, et al.
Ebiomedicine
|
July 19, 2016
Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants
Nina Lin, Oscar A Gonzalez, Ludy Registre, et al.
Open Forum Infectious Diseases
|
March 4, 2015
Plasmodium falciparum Infection Does Not Affect Human Immunodeficiency Virus Viral Load in Coinfected Rwandan Adults
Krishanthi Subramaniam, Rebeca M Plank, Nina Lin, et al.
JACC. Heart Failure
|
April 13, 2020
Heart Failure Outcomes and Associated Factors Among Veterans With Human Immunodeficiency Virus Infection
Sebhat Erqou, Lan Jiang, Gaurav Choudhary, et al.
The Journal of Infectious Diseases
|
June 29, 2012
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256
Timothy J Wilkin, Christina M Lalama, John McKinnon, et al.
The Lancet. HIV
|
October 6, 2017
Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort study
Krista L Dong, Amber Moodley, Douglas S Kwon, et al.
Page
of 5